Tiny Hagerstown bioscience company BioLinx, LLC, has been awarded a grant for cancer diagnosis research, according to the company's founder, biochemist Alex Kogon, Ph.D.
BioLinx, in the Technical Innovation Center at Hagerstown Community College, has been awarded a $114,000 Phase I, Small Business Innovation Research grant by the National Cancer Institute's Institute for Innovative Technology in Molecular Research in Cancer.
The grant was awarded based on the company's proposed development of a new early-detection method for cancer, Kogon said.
The concept is for a dipstick-type test that could be used to detect the presence of a substance, called T-antigen, which appears in body fluids when a cancerous tumor is beginning to form somewhere in the body, he said.
BioLinx scientists propose attaching a certain protein molecule that could sense the T-antigen to a special plastic using an agent that would cause the molecule to home in on the antigen and make the test reliable, Kogon said.